| COX-2/EP2-EP4/β-catenin signaling regulates patulin-induced intestinal cell proliferation and inflammation. | Toxicol Appl Pharmacol | 2018 Oct 1 | 30138657 |
| Pharmacokinetic drug interactions of the selective androgen receptor modulatorGTx-024(Enobosarm) with itraconazole, rifampin, probenecid, celecoxib androsuvastatin. | Invest New Drugs | 2016 Aug | 27105861 |
| Celecoxib, a COX-2 inhibitor, synergistically potentiates the anti-inflammatory activity of docosahexaenoic acid in macrophage cell line. | Immunopharmacol Immunotoxicol | 2016 | 26954392 |
| Interferon-alpha treatment induces depression-like behaviour accompanied byelevated hippocampal quinolinic acid levels in rats. | Behav Brain Res | 2015 Oct 15 | 26205824 |
| Evaluation of anti-osteoarthritic activity of Vigna mungo in papain induced osteoarthritis model. | Indian J Pharmacol | 2015 Jan-Feb | 25821313 |
| Determining cyclooxygenase-2 activity in three different test systems utilizing online-solid phase extraction-liquid chromatography-mass spectrometry for parallel quantification of prostaglandin E(2), D(2) and thromboxane B(2). | J Chromatogr A | 2015 Apr 24 | 25777050 |
| Food Polyphenols Fail to Cause a Biologically Relevant Reduction of COX-2 Activity. | PLoS One | 2015 | 26440517 |
| Effusanin E suppresses nasopharyngeal carcinoma cell growth by inhibiting NF-κBand COX-2 signaling. | PLoS One | 2014 Oct 21 | 25333664 |
| Antidepressant-like effect of celecoxib piroxicam in rat models of depression. | J Neural Transm (Vienna) | 2014 Jun | 24463888 |
| Development and characterization of a novel drug nanocarrier for oral delivery,based on self-assembled β-casein micelles. | J Control Release | 2012 Jun 10 | 22266050 |